Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis

Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis

Joy Q Jin,1,2 Riley K Spencer,2 Vidhatha Reddy,2 Tina Bhutani,2 Wilson Liao2 1School of Medicine, University of California at San Francisco, San Francisco, CA, USA; 2Department of Dermatology, University of California at San Francisco, San Francisco, CA, USACorrespondence: Joy Q Jin, Box 1212, Floor...

Full description

Bibliographic Details
Main Authors: Jin JQ, Spencer RK, Reddy V, Bhutani T, Liao W
Format: Article
Language:English
Published: Dove Medical Press 2023-05-01
Series:Therapeutics and Clinical Risk Management
Subjects:
apremilast
deucravacitinib
meta-analysis
placebo
plaque psoriasis
systematic review
Online Access:https://www.dovepress.com/clinical-utility-of-deucravacitinib-for-the-management-of-moderate-to--peer-reviewed-fulltext-article-TCRM

Internet

https://www.dovepress.com/clinical-utility-of-deucravacitinib-for-the-management-of-moderate-to--peer-reviewed-fulltext-article-TCRM

Similar Items